These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33510845)

  • 1. Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic review.
    Farshidpour M; Ahmed M; Junna S; Merchant JL
    World J Gastrointest Oncol; 2021 Jan; 13(1):1-11. PubMed ID: 33510845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Myeloid-Derived Suppressor Cells to Enhance the Antitumor Efficacy of Immune Checkpoint Blockade Therapy.
    Li X; Zhong J; Deng X; Guo X; Lu Y; Lin J; Huang X; Wang C
    Front Immunol; 2021; 12():754196. PubMed ID: 35003065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of myeloid-derived suppressor cells in gastrointestinal cancer.
    Cui C; Lan P; Fu L
    Cancer Commun (Lond); 2021 Jun; 41(6):442-471. PubMed ID: 33773092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Characterization of Myeloid-Derived Suppressor Cells in Tumor Microenvironment.
    Li Y; He H; Jihu R; Zhou J; Zeng R; Yan H
    Front Cell Dev Biol; 2021; 9():698532. PubMed ID: 34527668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies.
    Wang S; Zhao X; Wu S; Cui D; Xu Z
    Biomark Res; 2023 Mar; 11(1):34. PubMed ID: 36978204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.
    Safarzadeh E; Orangi M; Mohammadi H; Babaie F; Baradaran B
    J Cell Physiol; 2018 Apr; 233(4):3024-3036. PubMed ID: 28661031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
    Dysthe M; Parihar R
    Adv Exp Med Biol; 2020; 1224():117-140. PubMed ID: 32036608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment.
    Gao X; Sui H; Zhao S; Gao X; Su Y; Qu P
    Front Immunol; 2020; 11():585214. PubMed ID: 33613512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-derived suppressor cells in gastrointestinal cancers: A systematic review.
    Hirbod-Mobarakeh A; Mirghorbani M; Hajiju F; Marvi M; Bashiri K; Rezaei N
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1246-56. PubMed ID: 26729006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
    Parker KH; Beury DW; Ostrand-Rosenberg S
    Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer.
    Chaib M; Chauhan SC; Makowski L
    Front Cell Dev Biol; 2020; 8():351. PubMed ID: 32509781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
    Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
    Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs.
    Lakshmanachetty S; Cruz-Cruz J; Hoffmeyer E; Cole AP; Mitra SS
    Cells; 2021 Apr; 10(4):. PubMed ID: 33919732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.
    De Cicco P; Ercolano G; Ianaro A
    Front Immunol; 2020; 11():1680. PubMed ID: 32849585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization and quantification of
    Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
    Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer.
    Sasidharan Nair V; Saleh R; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Alajez NM; Abu Nada M; Elkord E
    Clin Epigenetics; 2020 Jan; 12(1):13. PubMed ID: 31941522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells.
    Lindau D; Gielen P; Kroesen M; Wesseling P; Adema GJ
    Immunology; 2013 Feb; 138(2):105-15. PubMed ID: 23216602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid-Derived Suppressor Cells in Solid Tumors.
    Ma T; Renz BW; Ilmer M; Koch D; Yang Y; Werner J; Bazhin AV
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment.
    Jin S; Yang Z; Hao X; Tang W; Ma W; Zong H
    Biomark Res; 2020; 8():21. PubMed ID: 32551121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.